Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Non-cash Items (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Non-cash Items for 2 consecutive years, with $7.7 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 17487.87% to $7.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Dec 2025, up 17487.87% year-over-year, with the annual reading at $7.7 million for FY2025, 17487.87% up from the prior year.
  • Non-cash Items for Q4 2025 was $7.7 million at Pyxis Oncology, up from $6.5 million in the prior quarter.
  • The five-year high for Non-cash Items was $7.7 million in Q4 2025, with the low at $44000.0 in Q4 2024.